Résumé
We present in this article a lightweight ontology named PGxO and a set of rules for its instantiation, which we developed as a frame for reconciling and tracing pharmacogenomics (PGx) knowledge. PGx studies how genomic variations impact variations in drug response phenotypes. Knowledge in PGx is typically composed of units that have the form of ternary relationships gene variant–drug–adverse event, stating that an adverse event may occur for patients having the gene variant when being exposed to the drug. These knowledge units (i) are available in reference databases, such as PharmGKB, are reported in the scientific biomedical literature and (ii) may be discovered by mining clinical data such as Electronic Health Records (EHRs). Therefore, knowledge in PGx is heterogeneously described (i.e., with various quality, granularity, vocabulary, etc.). It is consequently worth to extract, then compare, assertions from distinct resources. Using PGxO, one can represent multiple provenances for pharmacogenomic knowledge units, and reconcile duplicates when they come from distinct sources.